Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-52.29
Price to sales ratio
1.61

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3938
CGTX
Cognition Therapeutics, Inc. - Common Stock
1.06 USD0.00%+4.95%+15.22%-58.75%100.80 M USD
3947
KLRS
Kalaris Therapeutics, Inc. - Common Stock
4.10 USD+0.49%0.00%+23.49%-59.92%97.60 M USD
3976
PYPD
PolyPid Ltd. - Ordinary Shares
5.12 USD+0.20%+0.39%+21.62%+51.93%93.20 M USD
3978
ALDX
Aldeyra Therapeutics, Inc. - Common Stock
1.54 USD0.00%-1.28%-2.53%-73.72%92.90 M USD

Frequently asked questions about Fortress Biotech, Inc.

What is the Fortress Biotech, Inc. stock price today?

The current price of Fortress Biotech, Inc. (FBIO) is 2.80. Over the past 24 hours, the stock has changed by -0.36%. Follow the FBIO chart for real-time price dynamics.

What is the stock ticker of Fortress Biotech, Inc.?

Fortress Biotech, Inc. trades under the ticker FBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Fortress Biotech, Inc. stock going up?

FBIO has changed by 0.00% over the last week, -17.16% over the last month, and +13.82% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Fortress Biotech, Inc.?

Fortress Biotech, Inc. currently has a market capitalization of 93.38 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Fortress Biotech, Inc. release financial reports?

Yes. You can track Fortress Biotech, Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Fortress Biotech, Inc. earnings last quarter?

Last quarter, Fortress Biotech, Inc. reported earnings of -0.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Fortress Biotech, Inc. revenue for the last quarter?

Fortress Biotech, Inc. reported quarterly revenue of 18.72 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Fortress Biotech, Inc. net income for the last quarter?

Fortress Biotech, Inc. reported net income of -468 K for the last quarter. The previous quarter showed 110.37 M, which means net income changed by -100.42%.

How many employees does Fortress Biotech, Inc. have?

As of the latest available data, Fortress Biotech, Inc. has 78 employees. Workforce size can provide additional context about the company's scale and operations.

What is Fortress Biotech, Inc. EBITDA?

Fortress Biotech, Inc. EBITDA is -8.49 M, and its EBITDA margin is -45.36%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Fortress Biotech, Inc. stock?

You can buy Fortress Biotech, Inc. (FBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Fortress Biotech, Inc. stock?

Investing in Fortress Biotech, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FBIO chart and related analysis on metatrader.com as part of your research.

Fortress Biotech, Inc. - Common Stock

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

News